UCL Institute of Healthcare Engineering


Announcing the plenary speakers for BioMedEng22

21 March 2022

We are delighted to host our internationally-esteemed plenary speakers.

BioMedEng22 plenaries

BioMedEng is the UK’s largest gathering of biomedical engineers, medical engineers and bioengineers.
The next annual conference, BioMedEng22, will be held on Thursday 8 September to Friday 9 September 2022 at University College London in the heart of Bloomsbury, London. Expect to explore plenary sessions, keynote talks, break-out workshops, poster sessions, dedicated early-career researcher sessions and more. 

The organising committee are pleased to confirm the following plenary speakers will be joining us in September.

BioMedEng22 plenary speakers

Eric Aboagye

Prof Eric Aboagye is Professor of Cancer Pharmacology & Molecular Imaging and Director of the CRUK-EPSRC-MRC-NIHR Comprehensive Cancer Imaging Centre.

He joined the college after a PhD at the CRUK Beatson Laboratories in Glasgow, UK and post-doc fellowship at The Johns Hopkins University & Hospital in Baltimore, USA. His group is interested in the discovery and development of new methods for experimental and clinical cancer molecular imaging. In the past 5 years, the team has invented and translated three novel cancer diagnostics into human application. He has acted as an advisor to GE-Healthcare, GSK, Roche and Novartis.

Professor Aboagye was recipient of the 2009 Sir Mackenzie Davidson Medal and was  elected as a Fellow of the Academy of Medical Sciences in 2010. Academy Fellows are elected for outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge or for conspicuous service to healthcare.



Lesley Booth

Dr Lesley Booth BA DipLib MSc PhD MBE is the Director of Research and Patient and Public Integration at Bowel Research UK.

As the Director of Research and PPI, she plays a key role in developing and delivering the new charity’s research strategy and driving the research agenda. This includes identifying research priorities, the research grant and PhD programmes, facilitating and overseeing partnerships, promoting patient and public involvement on a wide range of research activities and the dissemination of research outcomes.

She was voted one of the First Fifty People to make York great in its first fifty years anniversary celebrations, receiving her MBE in 2012.

Lesley is a co-applicant on numerous NIHR grants and pan-European projects. She is a member of the ACPGBI Patients Liaison Group,  Advanced Cancer Coalition, NBOCA patient group and supports PPI interests for numerous institutions including UCL, King’s College London, Oxford, Imperial College Health Partners and Leeds Surgical Medtech.


Treena Arinzeh

Prof Treena Arinzeh is Professor of Biomedical Engineering at New Jersey Institute of Technology in Newark, New Jersey. She is known for her research on adult stem-cell therapy. She worked for several years as a project manager at a stem cell technology company, Osiris Therapeutics, Inc. Dr. Arinzeh joined the faculty of NJIT as one of the founding faculty members of the department of Biomedical Engineering and served as interim chairperson and graduate director.

Her most notable or cited work to date has been in the use of allogeneic mesenchymal stem cells (MSCs) with bioactive ceramics to induce bone formation in a large bone defect without the use of immunosuppressive therapy. This study served the basis for FDA approval to pursue clinical trials using allogeneic MSCs for various applications. Dr. Arinzeh has been recognized with numerous awards, including the National Science Foundation (NSF) CAREER Award and the Presidential Early Career Award for Scientists and Engineers (PECASE). She was nominated by the Governor of Connecticut to the Connecticut Stem Cell Research Advisory Committee. She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and the Biomedical Engineering Society (BMES). She recently served as the chairperson for the National Institutes of Health (NIH) Musculoskeletal Tissue Engineering (MTE) Study Section. She is currently a co-PI and the Director of Diversity of the NSF Science and Technology Center on Engineering Mechanobiology, which is a multi-institutional center with the University of Pennsylvania and Washington University in Saint Louis. She has also made a significant impact in the recruitment and mentoring of underrepresented minorities and women in biomedical engineering and other STEM fields.

Tim Chico

Prof Tim Chico is the British Heart Foundation Data Science Centre’s Associate Director and Theme Lead for Personal Monitoring Data.

Tim is Professor of Cardiovascular Medicine and honorary Consultant Cardiologist at Sheffield Teaching Hospitals NHS Trust and Research Director for Healthcare Data / AI in the Institute of In Silico Medicine (INSIGNEO) at the University of Sheffield. He brings a breadth of expertise in cardiovascular research and medicine and is an Academy of Medical Sciences “Future Leader in Innovation, Enterprise and Research”.






Purchase your tickets now for BioMedEng

Early bird pricing is available until the 9th July, and starts at £155 for BioMedEng members attending in-person. There is also an option to watch the talks online, from just £65 for members. 

Learn more and register for BioMedEng22